Antipsychotic
Drugs Market Research Report: Information by Generation (First Generation,
Second Generation), Types of Antipsychotics (Atypical Antipsychotics,
Miscellaneous Antipsychotics Agents), Therapeutic Applications(Schizophrenia,
Anxiety, Bipolar Disorder) and Region (the Americas, Europe, Asia-Pacific, and
the Middle East & Africa) - Forecast till 2025
Psychosis
is a collective term used to cover are a group of disorders that are regarding
the serious distortion of behavior, thought, recognition of reality, and
perception. Drugs that are useful for treating psychosis are called
antipsychotic drugs. A new report on the global Antipsychotic
Drugs Market Size
published by Market Research Future (MRFR), assays that this market can touch
success at 4.3% CAGR between 2017 and 2022. In terms of money value, the market
can be worth USD 18.5 Bn by the end of the forecast period.
Assaying
the market structure, this report accounts the future growth potential of the
market. It characterizes the strategies of the topmost market players in the
market and supports the competitive developments like research &
developments (R&D), mergers & acquisitions, new product developments,
and joint ventures, in the market.
The
most significant market driving factor for the global Antipsychotic Drugs
Market Size growth is unmet medical needs of an order of 35% and 50% of people
with mental disorders. Increasing the focus of governments and health care
organizations on mental health is also boosting the market. Other factors
contributing to the global Antipsychotic Drugs Market Size growth include
research & development research & development (R&D) on many
antipsychotic drugs. However, some factors that can hinder the global
Antipsychotic Drugs Market Size growth include social stigma faced by patients,
poor drug development pipeline, and a strict regulatory framework. The side
effects of antipsychotic drugs range from drowsiness, insomnia, vomiting to the
high addiction rate. Hence, many patients hesitate to use these drugs. The poor
efficiency and efficacy of antipsychotic drugs also hurt its market growth.
Market Segmentation
The
global Antipsychotic Drugs Market Size segmentation encompasses generations and
therapeutic applications. MRFR’s take on the market surveys various facets of
the market in-depth.
The
generations-based segmentation of this market covers the first generation,
second generation, and third generation. Regarding therapeutic applications,
the market has been segmented into bipolar disorder, dementia, depression,
schizophrenia, and others.
Browse
Complete Report : https://www.marketresearchfuture.com/reports/antipsychotic-drugs-market-2784
Regional Segmentation
A
geographical outlining of the global Antipsychotic Drugs Market Size covers the
Americas (North America & South America), Europe, Asia Pacific, and the
Middle East & Africa (MEA).
The
Americas is the largest regional market as North America alone holds the
potential of being a dominant market due to heavy investment in the R&D
related to medicines and drugs. Due to technological advancements and
availability of advanced medical facilities, North America is a bigger regional
market segment than South America. USA and Canada generate maximum market
revenue in this region. Many important key market players are based in the USA.
Two most important market driving factors in this region are excellent
reimbursements scenario in the USA and the rapid uptake of new drug molecules.
Most of the crucial market players are based in the USA.
Europe
is the second-largest regional market due to the high density of population and
other reasons being the same as in North America. The most powerful
country-specific markets in Europe are France, Germany, Italy, Spain, and the
UK. An inspection of the remaining countries in Europe featured in this report
speculate the huge contribution to market revenue from some other countries in
this region.
During
the forecast period, the Asia Pacific region can be the fastest growing
regional market high density of population, improving healthcare facilities,
and government efforts to improve healthcare, especially in China and India.
Other pivotal country-specific markets in this region are Japan and South
Korea. An observation of the remaining countries in the Asia Pacific region
featured in this report calculates the huge addition to market revenue from
some other countries.
The
MEA region holds the lowest share in the global market due to poor medical
facilities and lack of skilled professionals.
Key Players
Big
players in the global Antipsychotic Drugs Market Size AstraZeneca (UK),
Bristol-Myers Squibb (USA), Eli Lilly and Company (USA), GlaxoSmithKline PLC
(UK), Johnson & Johnson (USA), and Pfizer Inc. (USA).
Latest Industry News
·
ACADIA
Pharmaceuticals Inc. has announced its Phase 3 HARMONY study. This is going to
be a double-blind, placebo-controlled relapse prevention trial that would
evaluate pimavanserin for the treatment of dementia-related psychosis. 9 SEP 2019
No comments:
Post a Comment